FIELD: medicine. SUBSTANCE: method involves carrying out continuous perfusion of osmotic active 33% low molecular weight polyvinyl pyrrolidone solution at a rate of 10 ml/h in membrane capsule cavity set into omental bursa using microperistaltic bicanal pump in postoperative period for 7-9 days. EFFECT: prolonged survival period; accelerated treatment course; reduced risk of purulent complications; eliminated early toxicosis phenomena. 3 cl
Title | Year | Author | Number |
---|---|---|---|
TREATING ENDOTOXICOSIS IN PATIENTS WITH DESTRUCTIVE PANCREATITIS | 1999 |
|
RU2199326C2 |
METHOD FOR DECONTAMINATION OF GASTROINTESTINAL TRACT BY USING OZONE IN PANCREONECROSIS-SUFFERING PATIENTS | 2001 |
|
RU2194513C2 |
METHOD FOR ADJUSTING IMMUNITY DISORDERS BY APPLYING COMBINED ADMINISTRATION OF OZONIZED PHYSIOLOGICAL SALT SOLUTION AND HELIUMNEON LASER TO DESTRUCTIVE PANCREATITIS PATIENTS | 2001 |
|
RU2194546C2 |
METHOD TO PREDICT UREMIA IN PATIENTS WITH EXTERNAL DRAINING OF BILE DUCTS | 1995 |
|
RU2109284C1 |
METHOD OF SELECTION OF OZONE INDIVIDUAL DOSE WITHIN ACUTE PANCREATITIS TREATMENT | 2007 |
|
RU2328295C1 |
METHOD FOR APPLYING MEMBRANE DIALYSIS IN THE CASES OF PYOINFLAMMATORY DISEASES | 2003 |
|
RU2228758C1 |
METHOD FOR PREDICTING INFECTED PANCREONECROSIS | 2006 |
|
RU2319150C1 |
METHOD FOR PREDICTION OF LOCAL PURULENT COMPLICATIONS IN CASE OF DESTRUCTIVE FORMS OF ACUTE PANCREATITIS | 2001 |
|
RU2189041C1 |
METHOD FOR CORRECTING THE SYSTEM FOR ANTIOXIDANT PROTECTION AT DESTRUCTIVE PANCREATITIS | 2001 |
|
RU2186592C1 |
METHOD FOR TREATING CASES OF PANCREONECROSIS | 2000 |
|
RU2188045C2 |
Authors
Dates
2004-04-10—Published
2002-11-21—Filed